PTC Therapeutics | PTCT - Devedores Comerciais





Devedores Comerciais Alterar Data
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Amgen USD 9.14B 432M 2026-03
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Cytokinetics USD 6.83M 10.94M 2026-03
Daiichi Sankyo JPY 695.95B 79.1B 2025-12
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Gilead Sciences USD 4.74B 172M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Ionis Pharmaceuticals USD 74M 8M 2026-03
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Novartis USD 9.6B 2.69B 2026-03
Pfizer USD 16.17B 332M 2026-03
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
TG Therapeutics USD 392.05M 86.42M 2026-03
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03
Xencor USD 12M 17.3M 2026-03